The New England Journal of Medicine (NEJM) is an English-language peer-reviewed medical journal published by the Massachusetts Medical Society. It describes itself as the oldest continuously ...
New approval brings the medicine to an earlier treatment setting and a broader patient population.
AstraZeneca and Daiichi Sankyo's Enhertu has been approved in the US for the treatment of adults with HER2 breast cancer, after disease progression having had one or more hormone therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback